Rhythm Pharmaceuticals, Inc. RYTM Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s total costs & expenses?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total costs & expenses of $112.47M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total costs & expenses changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total costs & expenses increased by 41.1% year-over-year, from $79.71M to $112.47M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s total costs & expenses has grown at a 21.8% compound annual growth rate (CAGR), from $173.21M to $381.77M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to support its business activities during a specific period. It encompasses cost of goods sold, research and development expenditures, and selling, general, and administrative expenses. Monitoring this total provides insight into the company's overall cost structure and operational efficiency.